Close
CDMO Safety Testing 2026
Novotech

Press Releases

Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities

National Resilience, Inc. (Resilience), Expands Clinical and Commercial Drug Product Manufacturing Capabilities and CapacitiesNational Resilience, Inc. , a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today announced the expansion of the companyโ€™s clinical and commercial drug...

AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology

AbbVie Inc. and Tentarix Biotherapeutics today announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology. The collaboration will integrate AbbVie's expertise in oncology and immunology with Tentarix's proprietary Tentaclesโ„ข...

Cresset Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology

Cresset, an innovative provider of integrated in silico solutions for drug discovery announces a collaboration with Enamine, the worldโ€™s leading provider of chemical building blocks and drug discovery services to develop innovative new solutions for the early drug discovery...

Abzena Launches LabZient an Analytical Platform to Expedite the Path to IND for Antibodies

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its new analytical platform, LabZientโ„ข. The standardized and automated platform streamlines the assessment and validation of large molecules, which significantly reduces drug development...

Purolite and Repligen announce the commercial launch of a novel CH1 affinity resin for the purification of specialized mAbs

Purolite, an Ecolab company and leading manufacturer of synthetic and agarose-based bioprocessing resins, and Repligen Corporation , a life sciences company focused on bioprocessing technology leadership announced the commercial launch of Praestoยฎ CH1, a new 70ฮผm (micron) agarose-based affinity...

Sharp joins the Science Based Targets initiative (SBTi) to set greenhouse gas emissions reduction targets

Sharp, a leader in pharmaceutical packaging and clinical trial supply services, has announced that it has committed to the Science Based Targets initiative (STBi) in a significant step towards reducing greenhouse gas emissions across the company. Sustainability continues to be...

Recipharm, Medspray, and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology

Recipharm, a leading contract development and manufacturing organisation (CDMO) is pleased to announce an exclusive licence and collaboration agreement with Medspray and Resyca, to develop soft mist nasal delivery devices for single and combination drug products. This collaboration extends the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป